Comparing Efficacy and Safety of Stivant (AryoGen Bevacizumab) Versus Avastin in Metastatic Colorectal Cancer
NCT03288987
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
126
Enrollment
INDUSTRY
Sponsor class
Conditions
Metastatic Colorectal Cancer
Interventions
DRUG:
Bevacizumab + FOLFIRI-3
Sponsor
AryoGen Pharmed Co.